TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
172 hedge funds and large institutions have $2.15B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 75 increasing their positions, 55 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
39% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 41
78% less call options, than puts
Call options by funds: $349K | Put options by funds: $1.62M
Holders
172
Holding in Top 10
2
Calls
$349K
Puts
$1.62M
Top Buyers
| 1 | +$36.1M | |
| 2 | +$33.7M | |
| 3 | +$28.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.1M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$23.7M |
Top Sellers
| 1 | -$41.6M | |
| 2 | -$38.4M | |
| 3 | -$36.3M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$34.9M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$23M |